STOCK TITAN

Sotera Health Announces Fourth-Quarter and Full-Year 2022 Earnings Release Date 

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Sotera Health Company (Nasdaq: SHC) has announced the release date for its financial results for the fourth quarter and full year ending December 31, 2022. The results will be published on February 28, 2023, before the market opens. A conference call discussing the financial results will take place at 9:00 a.m. ET on the same day. Investors can participate by dialing the provided numbers or accessing the webcast via Sotera's Investor Relations website. Sotera Health, known for its sterilization solutions and lab services, operates through Sterigenics, Nordion, and Nelson Labs, focusing on its mission of safeguarding global health.

Positive
  • None.
Negative
  • None.

CLEVELAND, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2022 before the market opens on Tuesday, February 28, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.

To participate in the live call, please dial 1-866-777-2509 if dialing-in from the United States, or 1-412-317-5413 if dialing-in from other locations. For direct connection to the conference call, participants are strongly encouraged to register in advance at this link. A live webcast of the conference call and accompanying materials may also be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available later in the day on February 28th.

Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.

About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

Contacts 
Jason Peterson
Vice President & Treasurer, Sotera Health
IR@soterahealth.com
Sally J. Curley, IRC
Curley Global IR, LLC
IR@soterahealth.com
  
Kristin Gibbs
Chief Marketing Officer, Sotera Health
kgibbs@soterahealth.com
 
  

Source: Sotera Health Company


FAQ

When will Sotera Health release its financial results for 2022?

Sotera Health will release its financial results for the fourth quarter and full year ended December 31, 2022, on February 28, 2023.

What time is the Sotera Health conference call scheduled?

The conference call for discussing Sotera Health's financial results is scheduled for 9:00 a.m. ET on February 28, 2023.

How can I participate in the Sotera Health conference call?

To participate in the conference call, dial 1-866-777-2509 from the U.S. or 1-412-317-5413 from other locations. Advance registration is recommended.

Where can I find updates about Sotera Health's financial performance?

Updates can be found on the Investor Relations section of Sotera Health's website.

What is the focus of Sotera Health's business operations?

Sotera Health focuses on providing sterilization solutions and lab testing services for the healthcare industry.

Sotera Health Company

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Stock Data

3.60B
153.18M
2.47%
94.62%
3.17%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States of America
BROADVIEW HEIGHTS